Abstract: A stable aqueous NAD reagent useful in the measurement of analytes in biological fluids, particularly ethanol and lactate. For the determination of alcohol, the reagent contains alcohol dehydrogenase, pyrazole, NAD, SUTTOCIDE A and an aliphatic, zwitterionic buffer having a secondary or tertiary amine group. Preferred buffers are TAPSO, AMPSO, POPSO, TAPS and DIPSO. For the determination of lactate, the reagent contains lactate dehydrogenase, pyrazole, NAD, SUTTOCIDE A and an aliphatic, zwitterionic buffer having a secondary or tertiary amine group.
Type:
Grant
Filed:
January 31, 1997
Date of Patent:
September 8, 1998
Assignee:
Boehringer Mannheim Corporation
Inventors:
Allen R. Dorn, Catherine J. Hurt, Edward O. Ganser
Abstract: This invention is a surgical instrument, and specifically is a device for delivering embolic coils to a selected site within the vasculature of a human body. This instrument uses, and may include, the catheter used to place the embolic coil. In particular, the device is made up of a pusher wire having a distal tip which is configured to engage the proximal end of an embolic coil. The device may also include a cylindrical pusher which coaxially surrounds at least a portion of the pusher wire and cooperates in the disengagement of the coil from the pusher wire and the ejection of the vasoocclusive coil into the selected vascular site. The pusher wire's engagement tip may be of any selected and convenient shape, and may be grooved, if so desired, to enhance the engagement joint strength.
Abstract: This invention relates to novel polysubstituted benzimidazoles and compositions and their use in the treatment of viral infections. The polysubstituted benzimidazoles and compositions of the present invention exhibit antiviral properties against viruses of the herpes family, particularly human cytomegalovirus (HCMV) and herpes simplex viruses (HSV).
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
August 5, 1997
Assignee:
The Regents of the University of Michigan
Abstract: This invention relates to novel polysubstituted benzimidazoles and compositions and their use in the treatment of viral infections. The polysubstituted benzimidazoles and compositions of the present invention exhibit antiviral properties against viruses of the herpes family, particularly human cytomegalovirus (HCMV) and herpes simplex viruses (HSV).
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
July 8, 1997
Assignee:
The Regents of the University of Michigan